AzTrials
AzTrials

Weaning FailureFLOWNCT04496583

Fluid unLoading On Weaning (FLOW)

A study testing Fluid depletion strategy in people with Weaning Failure and Fluid Overload, run by Pontificia Universidad Catolica de Chile at 1 site in Chile.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if testing preload responsiveness, the normal physiologic state that means that changes in preload determine changes in cardiac output, allows an earlier and physiologically safer weaning from mechanical ventilation in critically ill patients with fluid overload, when compared… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Fluid depletion strategy
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteChile
Study dates
1 Jul 2021to Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Mechanical ventilation for >24 hours and <7 days
  • Patients who on the daily evaluation to assess their potential for weaning present fluid overload and, in consequence, require fluid depletion before the spontaneous breathing trial
  • Clinical condition resolving or hemodynamically stable condition with acceptable ventilatory status that allows an spontaneous breathing trial according to attending's criteria.

Who cannot join

  • Pregnancy
  • Do-not-resuscitate status
  • Child B or C liver cirrhosis
  • Circulatory instability
  • Acute coronary syndrome
  • Active bleeding
Show all 10Show fewer
  • Severe concomitant acute respiratory distress syndrome
  • Malnutrition
  • Muscle weakness severe enough to be considered by itself a risk for weaning failure
  • Patient should be excluded based on the opinion of the clinician/investigator (documented reason)

Trial locations and contacts

1 site in 1 country.

Eduardo Kattan, MD, MSc contact

+56994793024

e.kattan@gmail.com

Ricardo Castro contact

+56973986588

rcastro@ucchristus.cl

Chile1 site, 1 recruiting
  • Hospital Clínico UC CHRISTUS

    Santiago, RM, 8330077

    RICARDO CASTRO, MD, MPH, rcastro.med@gmail.com

    Recruiting

Other trials in Chile

About this study

Official title: Preload Responsiveness as a Signal to Start an Spontaneous Breathing Trial in Mechanically Ventilated Critically Ill Patients

The purpose of this study is to determine if testing preload responsiveness, the normal physiologic state that means that changes in preload determine changes in cardiac output, allows an earlier and physiologically safer weaning from mechanical ventilation in critically ill patients with fluid overload, when compared to a strategy of fluid removal aimed at obtaining a predetermined negative fluid balance.

Read the detailed description

Fluid overload is a state of global body accumulation of fluids with a deleterious impact in organ function. This condition is frequently found in critically ill patients after acute resuscitation. Its adverse impact is well demonstrated on weaning-induced heart failure, pulmonary and visceral edema, intraabdominal hypertension, etc., which results in longer mechanical ventilation and length of stay, and worse clinical outcomes. Despite these well-known facts, there are no guidelines on how to implement depletive strategies on this phase. The usual approach is to set in advance a desired negative fluid balance for the upcoming days, initiating diuretics or ultrafiltration in preparation for weaning from mechanical ventilation. Unfortunately, this strategy frequently results in excessive and detrimental fluid removal.

A more physiologic approach to guide fluid removal is testing preload responsiveness, which is the normal physiologic state, and means that changes in preload determine changes in cardiac output, with mild or null increment in filling pressures. In contrast, preload unresponsiveness corresponds to a state in which preload increases do not increase stroke volume but produce large increments in filling pressures. This altered state is usually present in patients with fluid overload. Preload responsiveness can be tested routinely in the ICU by assessing the interactions between preload and cardiac output.

Now, in usual clinical practice, weaning from mechanical ventilation is accomplished through a process called the spontaneous breathing trial (SBT), which is a standardized test to mimic the real conditions of breathing without the ventilator, before extubation. One-third of patients fail the initial SBT, which determines a prolonged or difficult weaning and longer stay on mechanical ventilation. Importantly, one of the main determinants of this problem is fluid overload. The pathophysiologic explanation lays in that when switching from positive pressure ventilation to spontaneous breathing, intrathoracic pressure goes from being steadily positive across the ventilatory cycle to markedly negative, promoting increased preload and impeding left ventricular ejection, and this phenomenon is associated to preload unresponsiveness. Interestingly, in most patients with fluid overload, preload responsiveness can be restored just a few hours after starting fluid removal, while modifying fluid balance may take several days. Notably, some patients may persist with preload unresponsiveness even after achieving significant fluid removal.

The investigators hypothesized that in mechanically ventilated patients with fluid overload, a fluid removal strategy aimed at attaining a state of preload responsiveness associates with a decreased incidence of weaning failure from cardiovascular origin, shorter weaning time, and less depletion-induced hypoperfusion events, metabolic derangements and kidney stress compared to patients depleted with a fluid removal strategy aimed at obtaining a predetermined negative fluid balance.

To confirm this hypothesis, the investigators propose a prospective randomized study on 46 critically ill mechanically ventilated patients with fluid overload, comparing these two strategies of depletion and their impact on weaning development and other related systemic functions. Throughout all the protocol, patients will receive general monitoring and management according to ICU standards, plus protocol-specific monitoring that will be added since randomization and before and after SBT attempts, for up to 72 h. Patients will be followed-up for 28 days.

If the investigators' hypothesis is confirmed, it may generate a change in the paradigm of managing fluid overload in critically ill patients, since the physiologic endpoint preload responsiveness may suffice as the valid target and safety parameter to appropriately discontinue mechanical ventilation, shortening the days on mechanical ventilation, the ICU length of stay, and many other costs associated, among additional benefits.

Being tested
Fluid depletion strategy
Medical subject headings
Edema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fluid depletion strategyOther

    The fluid depletion strategy will be individualized depending on the response to the standardized furosemide test (one-time dose of 1.0 or 1.5 mg/kg depending on prior furosemide-exposure) with a urinary output (UO) cutoff of 200 ml at 2 hours. The desired depletion endpoint will be targeted by using diuretics (40 mg q6h iv initially, adjusting dose by UO) or ultrafiltration (UF) if UO <200 ml/2h

Study groups in NCT04496583
Study groupRoleWhat they receive
Fluid Balance Depletive Strategy GroupActive comparatorPatients with fluid overload under a depletive strategy to attain a predetermined negative balance
Receives: Other: Fluid depletion strategy
Preload Responsiveness Depletive Strategy GroupExperimentalPatients with fluid overload under a depletive strategy to attain a state of preload responsiveness
Receives: Other: Fluid depletion strategy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients on each study group presenting weaning-induced pulmonary edema or weaning failure from cardiovascular origin

    Development of signs of cardiac failure and acute pulmonary edema during the spontaneous breathing trial.

    Measured: 72 hours

  2. Mean and standard deviation of T time between the starting of fluid depletion and consolidated weaning from mechanical ventilation on each study group.

    Time between the starting of fluid depletion and consolidated weaning from mechanical ventilation, measured in hours and days.

    Measured: 7 days

Secondary outcomes (3)
  1. Proportion of patients on each study group presenting weaning-induced global and regional hypoperfusion (lactate, capillary refill time, ScvO2, dCO2)

    Development of clinical and laboratory signs of global and regional hypoperfusion due to depletive measures.

    Measured: 72 hours

  2. Proportion of patients on each study group presenting depletion-induced renal dysfunction assessed by renal stress biomarkers variation.

    Development of laboratory signs of renal compromise due to fluid depletion

    Measured: 72 hours

  3. Proportion of patients on each study group presenting depletion-induced acid-base and electrolyte disturbances.

    Development of laboratory signs of acid-base and electrolyte derangements due to fluid depletion.

    Measured: 72 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2020
  2. Study start1 Jul 2021
  3. Primary completionJun 2023 (estimated)
  4. Study completionJun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized prospective controlled study of parallel groups
Masking
None (open label)
Enrolment
46 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04496583
Sponsor's protocol ID
1200248
Acronym
FLOW
Status last verified
Jan 2021
First submitted
29 Jul 2020
Last updated
5 Sep 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Castro R, Kattan E, Hernandez G, Bakker J. Differential Cardiac Responses after Passive Leg Raising. J Clin Monit Comput. 2024 Oct;38(5):991-996. doi: 10.1007/s10877-024-01180-z. Epub 2024 Jun 6.

    PubMed 38844602

Questions about this trial

What is this clinical trial studying?

A study testing Fluid depletion strategy in people with Weaning Failure and Fluid Overload, run by Pontificia Universidad Catolica de Chile at 1 site in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eduardo Kattan, MD, MSc (+56994793024, e.kattan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients on each study group presenting weaning-induced pulmonary edema or weaning failure from cardiovascular origin (time frame: 72 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04496583, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in